20-22 APR 2023

Curietherapies 2023: Advanced Targeting for Personalized Patient Care

Joanne Alfieri, MD

Joanne Alfieri, MD

McGill University Health Center

J Joanne Alfieri is an associate professor in the Department of Oncology, McGill University since February 2012. She is a radiation oncologist who specializes in the treatment of gynaecological and gastrointestinal malignancies at the McGill University Health Centre. Dr. Alfieri earned her medical degree and her post-graduate radiation oncology training at McGill. She completed a Post-graduate Fellowship in Gynaecology Oncology and MRI-guided Brachytherapy at the Peter MacCallum Cancer Centre in Melbourne, Australia.  Dr. Alfieri is the lead for the gynecological site group as well as the brachytherapy lead for the MUHC. She initiated the MRI-guided brachytherapy program at McGill, and her current research interests lie in the evaluation of this program with the aim of improving the long-term outcomes and minimizing treatment-related toxicity in gynaecological cancer patients as well as in investigating alternate treatment options for locally advanced cervix cancer.  She has a keen interest in medical education and is the post-graduate residency training Program Director for radiation oncology since February 2015 as well as Associate Chair (Education) for the Gerald Bronfman Department of Oncology of McGill University where oversees undergraduate, graduate, and post-graduate training programs in medical, surgical and radiation oncology. Merci!      

April 21, 2023 Sessions
09:35 - 09:50 gyn Q&A interactive
Francois Bachand, MD

Francois Bachand, MD

B.C. Cancer

I grew up in Sherbrooke Qc, did my Medical School at the Université de Sherbrooke (the family thing to do, my dad, 2 of my uncles and 2 of my cousins trained in the med school), then residency at Université Laval in Quebec City, then fellowship in GYN Radiation Oncology in Vancouver (completed in 2010).  I had planned to go back to Quebec but met partner Corey and stayed in BC since. I worked at the Cancer Clinics in Surrey and Abbotsford for 10 months then accepted an offer from Kelowna.  I opened the MRI Brachy program for cervix cancer along the way, was the GYNRO Lead for several years, the GURO lead for several other years, Department Head in Kelowna for almost 7 years, on the executive board for the RO Examination at the Royal College of Physicians and Surgeons of Canada for 8 years, on the executive board of the Two Worlds Cancer Collaboration (worked in India for several years) and led several transitions like the ETHOS, Kamloops clinic and Elekta Brachytherapy in BC. I have a 4 year-old son (Sasha) and he is the reason behind my decision to move back to Quebec city in April 2023.  I look forward to reconnect with my colleagues in the province of Quebec.

Boris Bahoric, MD

Boris Bahoric, MD

Jewish General Hospital

Dr. Bahoric completed his medical school in Rijeka, Croatia. He completed his Royal College Fellowship Program in Radiation oncology in Toronto. He works as staff radiation oncologist at the Jewish General Hospital in Montreal. He is assistant professor at McGill University. Apart from teaching he is involved in various administrative activities. His areas of interest and expertise are the gynecological, genitourinary and hematological malignancies. Particularly, he is interested in brachytherapy. He offers both intracavitary and interstitial for gynecological malignancies. He performs adjuvant accelerated partial breast irradiation via interstitial brachytherapy. Dr. Bahoric participates in nationwide studies in prostate cancer. As part of the studies he offers and performs HDR prostate brachytherapy. He is past president of Canadian Brachytherapy Group and is still active participant in this group.

April 22, 2023 Sessions
10:50 - 11:00 Toxicity of breast cancer interstitial brachytherapy
Luc Beaulieu, Physicien médical

Luc Beaulieu, Physicien médical

Centre hospitalier universitaire de Québec

Dr. Beaulieu is a full professor, Director of the CAMPEP graduate program and also Director of the Cancer Research Centre at Université Laval. He served on the Board of the Canadian Organization of Medical Physicists as President Elect, President and Past President (2010-2016). He is a member of the AAPM Brachytherapy Subcommittee as well as two associated Working Groups (Robotics and Clinical Applications), is the Chair of TG317 on tracking technology for brachytherapy, a member of the ESTRO In Vivo dosimetry working group, was the Chair of TG-186 and until recently led the AAPM/ESTRO/ABG Working Group on Model-Based Dose Calculations in Brachytherapy. He has mentored over 150 highly qualified personals, published 220 peer-reviewed manuscripts and 465 refereed abstracts at national and international meetings. He is a recognized expert on topics related to scintillation dosimetry and brachytherapy. Luc

Jean-Pierre Bissonnette, Physicien médical

Jean-Pierre Bissonnette, Physicien médical

Dr. Jean-Pierre Bissonnette is the Associate Head for Professional and Academic Affairs for the Department of Medical Physics at the Princess Margaret Cancer Centre, where he has been employed since 2003. He obtained his M.Sc. from McGill University and his Ph.D. from the University of Western Ontario, in 1996. He is an Associate Professor at the University of Toronto Departments of Radiation Oncology and Medical Biophysics.With 75 peer-reviewed publications, Dr. Bissonnette has been active in several areas relevant to radiotherapy, including quality assurance and patient safety, high-precision radiotherapy for the brain and the lung, post-graduate education, and using PET, CT, and CBCT images to monitor treatment response for lung cancer patients. He chaired the AAPM TG-179 task group on CT-based image-guidance. Current research topics include dose reconstruction based on image-guidance images, image-based adaptation of therapy, and using statistical tools to rationalize and limit the cost of quality control.

April 21, 2023 Sessions
10:30 - 10:45 guiding principles for program implantation
Charlotte Brouwer, Physicienne médical

Charlotte Brouwer, Physicienne médical

University Medical Center Groningen

Charlotte Brouwer is medical physicist and team leader medical physics at the department of radiation oncology at the University Medical Center Groningen. Her clinical and research interests include auto-segmentation, adaptive radiotherapy and the introduction of AI-based methods into clinical practice. She is a member of several national and international working groups on the introduction of AI into clinical practice.

April 21, 2023 Sessions
14:40 - 15:00 Is automated brachytherapy ready for clinical practice?

Albert Chang, MD

...

April 22, 2023 Sessions
08:30 - 08:50 Interstitial brachytherapy for renal cancer

Jennifer Croke, MD

Princess Margaret Hospital

...

Juanita Crook, MD

Juanita Crook, MD

BC Cancer

Dr Crook did her medical training at the University of Toronto, Residency in Radiation Oncology at the Princess Margaret Hospital and is currently a Full Professor of Radiation Oncology at the University of British Columbia. She is a staff Radiation Oncologist in Kelowna BC where she has developed image-guided HDR gynecologic brachytherapy, US-planned HDR prostate brachytherapy, HDR interstitial and surface mold penile brachytherapy and permanent seed brachytherapy for breast cancer. She is former president of the Board of the American Brachytherapy Society, recipient of the Thom Shanahan Distinguished Brachytherapy Educator Award and the ABS 2017 Henschke Award. She is also the first to hold a Brachytherapy Research Chair position in British Columbia.

Philip Devlin, MD

Philip Devlin, MD

Dana-Farber/Brigham and Women’s Cancer Center

Phillip M. Devlin, MD, FACR, FASTRO, FFRRCSI(Hon) is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. Dr. Devlin earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996.   In addition to lecturing extensively both nationally and internationally, Dr. Devlin has more than 100 published manuscripts and book chapters, and is editor of the text, Brachytherapy: Applications and Techniques, now in its second edition. He is a past President of the Massachusetts Radiological Society and was previously a member of the Board of Directors of the American Society for Radiation Oncology (ASTRO). In 2008, he was named a Fellow of the American College of Radiology (FACR), and in 2013 he became both a Fellow of ASTRO (FASTRO) and a Faculty of Radiology Honorary Fellow in the Royal College of Surgeons of Ireland (FFRRCSI[Hon]) and a Fellow of the American Brachytherapy Society. Dr. Devlin led two funded studies as part of the ACR’s Quality Research in Radiation Oncology (QRRO) project. His current research focus is on radioreponsiveness and gene expression in cutaneous lymphoma treated with brachytherapy. He continues to lead internationally in developing and deploying innovative brachytherapy techniques to expand the scope of practice, teaching and research.  

April 22, 2023 Sessions
08:10 - 08:30 Brachytherapy for oral cavity cancer
Joe Hsu, MD

Joe Hsu, MD

UCSF Helen Diller Family Comprehensive Cancer Center

Dr. I-Chow "Joe" Hsu is an internationally recognized radiation oncologist with special expertises in brachytherapy and hyperthermia. Dr. Hsu’s research investigates the application of Hight Dose Rate (HDR) brachytherapy, a highly precise and conformal treatment that delivers radiotherapy by temporarily placing a minute radioactive source in the tumor using minimal invasive, image guided procedures.  His research in hyperthermia, a moderate temperature elevation (40-45° C) of the targeted tumor, explores the synergy between thermal therapy and radiotherapy to improve treatment efficacy without increasing treatment related toxicity.  His research in the treatment of genitourinary and gynecologic malignancies have lead to improved clinical outcomes and effective novel treatments for challenging clinical conditions. Dr. Hsu earned a medical degree at the Johns Hopkins School of Medicine. He is an active member of American Society for Radiation Oncology, American Brachytherapy Society and Society for Thermal Medicine.  He has been recognized as a Fellow of American College of Radiology and as a Fellow of American Society for Radiation Oncology.

April 21, 2023 Sessions
08:00 - 08:20 Adaptive personalized brachytherapy for gyn cancer
Fleur Huang, MD

Fleur Huang, MD

Cross Cancer Institute Edmonton

Dr. Fleur Huang is a radiation oncologist at the Cross Cancer Institute in Edmonton, and Associate Professor in the Department of Oncology at the University of Alberta, where she is a member of the Women and Children’s Health Research Institute. She maintains a busy clinical practice, with focus on women's cancers and palliative radiotherapy. Dr. Huang holds a medical degree from McGill University, where she also completed residency in Radiation Oncology. This was followed by Breast and Gynecologic subspecialty training at the Princess Margaret Hospital, University of Toronto. While growing her clinical practice, and deepening professional interests in Global Health and Health Systems, she earned an MPH at the Johns Hopkins Bloomberg School of Public Health. Dr. Huang has advanced her perspectives through study in places as diverse as the International Space University / Pôle Universitaire Européen de Strasbourg and Singapore Management University, more recently she was among the inaugural cohort of the NCI’s Multilevel Intervention Training Institute. In 2015, Dr. Huang led a team selected to take part in NCI-ASCO’s Teams in Cancer Care Delivery initiative (healthcaredelivery.cancer.gov/healthcare/nci-asco.html). She is a core member of CancerCare Alberta’s Brachytherapy Centre of Excellence working group. With broad-ranging activities in research and teaching, some of Dr. Huang’s latest multidisciplinary efforts have explored machine learning for predictive modeling of MRI uterine deformation from brachytherapy tandem placement, and first-in-kind prototyping of a virtual reality simulator for cervical brachytherapy intracavitary/interstitial applicator insertion. She has been participating in the EMBRACE Collaborative Group (www.embracestudy.dk) since her first study enrolment in 2011, and still leads the team that was among the top-10 accruers to EMBRACE-I.

April 21, 2023 Sessions
08:30 - 08:50 Limiting treatment toxicity (precision or escalation
Marjory Jolicoeur, MD

Marjory Jolicoeur, MD

Université de Montréal - Hôpital Charles Lemoyne

Dr. Jolicoeur had her medical degree along with a Ph.D in Molecular biology and completed her radiation oncology residency at University of Montreal in 1996. she completed a brachytherapy fellowship at the Centre Georges-François Leclerc located in Dijon France. In 1997 she started working at the department of Radiation Oncology of University of Montréal, where she still holds a position as a professor of Radiation Oncology. In 1999 she was appointed to the planning and construction of the new department of Radiation Oncology of Hospital Charles LeMoyne. The facility, which started his activities in 2011, has a comprehensive image guided brachytherapy program. In 2011 she founded “Curietherapies”. As a brachytherapy specialist, she has special research interests in the application of brachytherapy in area such as breast, genitourinary and gynecologic cancers. Her main focus is in the development of image guided implant procedures, the use of MRI in brachytherapy and the precision delivery of conformal high dose rate brachytherapy.

Nathalie Lebel, ---

...

April 21, 2023 Sessions
09:30 - 09:35 Patient insight in gyn brachytherapy
Eric Leung, MD

Eric Leung, MD

Sunnybrook Health Sciences Centre

Eric Leung is an Assistant Professor at the University of Toronto and a Clinician-Investigator in the Department of Radiation Oncology at Sunnybrook Odette Cancer Centre. He is originally from Saint John New Brunswick and graduated from medical school at the Memorial University of Newfoundland.  He completed his residency and fellowship training at U of T and specializes in interstitial and MR-guided brachytherapy.  Dr. Leung has an interest in cervical cancer clinical trials and is a member of the Cervix Core Committee at NRG Oncology and the Cervix Executive Committee at CCTG. His other academic interests include translational studies in cervix cancer including metabolic imaging for patients with locally advanced gynecological tumours. 

April 21, 2023 Sessions
09:35 - 09:50 gyn Q&A interactive
André-Guy Martin, MD

André-Guy Martin, MD

Centre Hospitalier Universitaire de Quebec

Fellowship en curiethérapie; Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA MSc médecine expérimentale; Faculté de médecine, University Laval, Québec, Québec “Diplôme d’étude supérieurs en radio-oncologie”; University Laval, Québec, Québec Doctorat en médecine; Faculté de médecine, Université Laval, Québec, Québec Bachelier en Pharmacie; École de pharmacie, Université Laval, Québec, Québec

Alvaro Martinez, MD

Alvaro Martinez, MD

21st Century Oncology of Michigan

Alvaro A. Martinez, M.D. received his medical degree from Universidad Javeriana in Bogota, Colombia. He completed a radiation oncology residency program at the Memorial Sloan-Kettering Cancer Center in New York. Following his residency, he became an Assistant Professor at Stanford University Medical School in Palo Alto, California. In 1981, he joined the department of Oncology at Mayo Clinic Medical School in Rochester, Minnesota where he achieved the position of Associate Professor. He was appointed Chairman of the department of Radiation Oncology at Beaumont Hospital Royal Oak, Michigan in 1985 where he was a Professor of Radiation Oncology at Oakland University William Beaumont Medical school. For the past five years, he has been a Senior VP of Scientific and Clinical Strategy at 21st Century Oncology of Michigan, a division of Michigan Health care professionals. Taking advantage of his surgical training, Dr. Martinez achieved outstanding expertise in brachytherapy and he designed special applicators which are widely used for the treatment of patients with gynecological and other pelvic malignancies. He is a member of numerous national and international professional organizations and is highly regarded by his peers for his professional accomplishments. He was president of the Michigan Society of Therapeutic Radiology in 1989 and president of the American Brachytherapy Society in 1991. Dr. Martinez is certified in radiation oncology by the American Board of Radiology and was awarded a fellowship in the American College of Radiology. Dr. Martinez has been a member of several National Cancer Institute review committees. He has been an associate editor for many national and international medical journals, and has contributed to more than 340 articles in prestigious scientific medical journals. In additional, he has written and contributed to more than 45 chapters in textbooks.

Geetha Menon, Physicien médical

...

Gerard Morton, MD

Gerard Morton, MD

Sunnybrook Hospital

Dr. Gerard Morton is a radiation oncologist at the Sunnybrook Odette Cancer Centre and an associate professor at the University of Toronto.  He has a clinical and academic focus in prostate cancer and brachytherapy, is program director of the University of Toronto Brachytherapy AFC training program, and is chair of the Royal College Brachytherapy AFC committee.  He co-chairs several ongoing multicentre clinical trials, is co-chair of the ASTRO Annual Meeting GU Track, and is North American Editor for Clinical Oncology.  He has published extensively on prostate cancer.   ...

Nadia Octave, Physicienne médical

CHUQ

...

April 21, 2023 Sessions
10:45 - 11:00 Step by step program implantation
Primoz Petric, MD

Primoz Petric, MD

University Hospital Zurich

I am a Senior Consultant and  Brachytherapy Lead at Clinic for Radiation Oncology, University Hospital Zürich,Switzerland, and Assoc. Professor at Aarhus University Hospital, Denmark. Since 2009, I have been a Facultymember at ESTRO course on Gynae malignancies. I am the Founder and Course Director of BrachyTerra, a free and non-profit online teaching platform for low-middle-income countries. I teach/have taught at other events, includingIAEA courses & workshops, organized by the Medical University of Vienna and Aarhus University Hospital. I ama member of Gyn GEC ESTRO Group and collaborate(d) in EMBRACE and retro-EMBRACE studies. I was a consultantto the ICRU 89 Report and (co-)authored several manuscripts, book chapters, guidelines, and lectures atinternational conferences.

April 22, 2023 Sessions
09:10 - 09:40 Brachytherapy for anal cancer
Alexandra Rink, Physicienne médical

Alexandra Rink, Physicienne médical

Princess Margaret Cancer Center

Alexandra Rink is a Lead Brachytherapy Physicist at the Princess Margaret Cancer Centre, a member of Ontario Health Gynecological Cancers Community of Practice, and an Assistant Professor in the Departments of Radiation Oncology and Medical Biophysics, at the University of Toronto. She completed her Ph.D. in the Department of Medical Biophysics under the co-supervision of Drs. Jaffray and Vitkin in 2008, focusing on in vivo methods for patient dosimetry.  After completing her Medical Physics residency at the University of Toronto, she joined the Medical Physics department at the Princess Margaret Cancer Centre in 2010. Alexandra’s passions are in vivo dosimetry and improvement in quality of care for brachytherapy patients through the application of Artificial Intelligence and Deep Learning methods. 

David Roberge, MD

...

April 22, 2023 Sessions
07:50 - 08:10 Brachytherapy for Occular tumors
Pandit Subah, MD

Pandit Subah, MD

Dr. Subhas Pandit is radiation oncologist at Kathmandu Cancer Center, Nepal. He completed his residency in Radiation Oncology from All India Institute of Medical Sciences(AIIMS) ,New Delhi in 2010. After graduating he has been working in field of cancer care in Nepal. His areas of interest are Head and Neck , breast cancers and  gynecologic malignancy. He was involved in starting the first IMRT program in Nepal. He is now active in expanding brachytherapy services in the country . He is particularly interested in brachytherapy treatment of gynecologic, skin, head and neck and interstitial brachytherapy in oligo-metastatic diseases. He has authored book chapters in oncology books.

April 21, 2023 Sessions
11:15 - 11:35 First Years of a Brachytherapy Program

Stephane Supiot, MD

Institut de Cancérologie de l'Ouest, Nantes Université

...

Dany Truchon, Physicien médical

Dany Truchon, Physicien médical

Hôpital Charles Lemoyne

After obtaining an MSc in physics at Université Laval in 2009, Dany worked in Quebec’s health system before obtaining his MSc in Medical Physics in 2015 at Université de Montréal.  Since then, he’s working at Hopital Charles-LeMoyne in the Radio-Oncology department.  His fields of expertise are Brachytherapy, TomoTherapy, and Machine QA.

April 21, 2023 Sessions
11:00 - 11:15 Brachytherapy QA: How To Avoid Incidents
11:45 - 11:55 Q&A